Profile data is unavailable for this security.
About the company
PT Merck Tbk is an Indonesia-based vibrant science and technology company. The Company delivers personalized treatments for serious diseases and enable people to achieve their dream of becoming parents. The Company operates through three segments: Biopharma (ethical products), Consumer Health (over-the-counter products) and Others.
- Revenue in IDR (TTM)934.62bn
- Net income in IDR124.91bn
- Incorporated1970
- Employees376.00
- LocationMerck Tbk PTJl. TB. Simatupang No. 8, Pasar ReboJAKARTA TIMUR 13760IndonesiaIDN
- Phone+62 28565600
- Fax+62 28565601
- Websitehttps://www.merckgroup.com/id-id
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Procaps Group SA | 6.57tn | 827.69bn | 1.42tn | 5.50k | 1.53 | 2.28 | 1.29 | 0.2166 | 0.5209 | 0.5209 | 4.16 | 0.3491 | 0.854 | 1.87 | 3.38 | 75,290.18 | 10.77 | -- | 19.01 | -- | 55.04 | -- | 12.61 | -- | 0.9861 | -- | 0.8829 | -- | 0.0434 | -- | 142.18 | -- | -- | -- |
| Chunghwa Chemical Synthsis&Biotech CoLtd | 732.93bn | 57.22bn | 1.45tn | 243.00 | 25.44 | 0.8921 | 9.63 | 1.98 | 1.51 | 1.51 | 19.37 | 43.16 | 0.3039 | 1.02 | 5.27 | -- | 2.37 | 9.03 | 2.73 | 10.56 | 32.33 | 43.26 | 7.81 | 20.15 | 0.7205 | -- | 0.2315 | 24.83 | -1.45 | 15.40 | -43.14 | 2.49 | 36.95 | -7.79 |
| Biosyent Inc | 381.44bn | 80.64bn | 1.46tn | 0.00 | 18.39 | 3.60 | 17.04 | 3.84 | 0.5988 | 0.5988 | 2.83 | 3.06 | 0.8352 | 1.34 | 7.74 | -- | 17.66 | 14.77 | 20.16 | 16.92 | 79.77 | 79.74 | 21.14 | 19.99 | 4.90 | -- | 0.0309 | 9.26 | 13.12 | 7.97 | 18.35 | 2.52 | -2.67 | -- |
| Bangkok Lab and Cosmetic PCL | 692.90bn | 75.61bn | 1.47tn | 698.00 | 19.42 | 2.01 | 14.25 | 2.12 | 0.278 | 0.278 | 2.55 | 2.69 | 0.6961 | 2.56 | 4.73 | 2,190,737.00 | 7.81 | 6.01 | 9.71 | 13.28 | 30.74 | 27.33 | 11.22 | 5.68 | 3.08 | 16.42 | 0.1158 | -- | 8.50 | 17.54 | 15.65 | 51.84 | 19.54 | -- |
| Nectar Lifesciences Ltd | 3.10tn | 11.53bn | 1.48tn | 1.69k | 128.20 | -- | 11.80 | 0.4795 | 0.275 | 0.275 | 73.96 | -- | -- | -- | -- | 9,782,218.00 | -- | -0.2956 | -- | -0.541 | 29.64 | 16.49 | 0.3725 | -0.4053 | -- | 1.06 | -- | -- | 10.53 | -9.56 | 120.66 | -36.29 | -5.06 | -- |
| Pak Fah Yeow International Ltd | 540.38bn | 196.53bn | 1.49tn | 101.00 | 7.56 | 0.9705 | 7.03 | 2.75 | 0.3094 | 0.3094 | 0.8507 | 2.41 | 0.2869 | 2.84 | 23.53 | 2,600,118.00 | 10.44 | 3.99 | 11.32 | 4.18 | 87.05 | 80.79 | 36.37 | 21.27 | 4.22 | 5.26 | 0.0055 | 100.68 | 76.06 | 12.94 | 250.66 | 23.02 | 18.83 | -8.06 |
| Turk Ilac Ve Serum Sanayi AS | 1.18tn | 42.61bn | 1.49tn | 465.00 | 34.87 | 1.85 | 22.13 | 1.25 | 0.5704 | 0.5704 | 15.85 | 10.77 | 0.998 | 7.39 | 2.42 | 5,842,276.00 | 3.59 | 3.05 | 5.11 | 5.26 | 31.30 | 23.44 | 3.60 | 2.36 | 1.97 | 1.16 | 0.4749 | 0.00 | 16.88 | 81.44 | 229.47 | 49.00 | 37.65 | -- |
| Biome Australia Ltd | 133.76bn | -17.09bn | 1.50tn | 30.00 | -- | 49.63 | -- | 11.23 | -0.0082 | -0.0082 | 0.0628 | 0.0135 | 1.65 | 2.08 | 6.06 | -- | -21.09 | -70.48 | -43.35 | -106.49 | 61.01 | 59.73 | -12.78 | -62.17 | 1.13 | -10.02 | 0.3087 | -- | 71.44 | 102.11 | 45.75 | -- | -47.07 | -- |
| Vistin Pharma ASA | 602.24bn | 87.25bn | 1.53tn | 77.00 | 17.49 | 3.45 | 13.36 | 2.53 | 1.38 | 1.38 | 9.55 | 7.01 | 1.09 | 1.89 | 7.27 | 5,501,130.00 | 15.85 | 1.73 | 19.26 | 2.11 | 64.84 | 58.92 | 14.49 | 2.36 | 1.06 | 21.05 | 0.0178 | 286.16 | 51.35 | 16.95 | 1,066.84 | -- | -0.1922 | -- |
| Merck Tbk PT | 934.62bn | 124.91bn | 1.55tn | 376.00 | 12.41 | 2.12 | 9.32 | 1.66 | 278.81 | 278.81 | 2,086.21 | 1,628.52 | 1.01 | 1.61 | 6.34 | 2,396,464,000.00 | 13.54 | 12.78 | 16.05 | 18.12 | 34.90 | 40.53 | 13.36 | 14.06 | 1.70 | -- | 0.0247 | 79.25 | -14.51 | 9.46 | -0.8884 | 36.67 | -3.13 | -34.05 |
Data as of Nov 15 2024. Currency figures normalised to Merck Tbk PT's reporting currency: Indonesian Rupiah IDR
0.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Samarang LLPas of 30 Jun 2022 | 2.92m | 0.65% |
Data from 30 Jun 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
